Yuta Ohno Selected Research

Yuta Ohno Research Topics

Disease

5	Retinal Degeneration 01/2018 - 11/2012
3	Retinal Diseases 05/2022 - 11/2013
2	Inflammation (Inflammations) 11/2020 - 03/2016
2	Neoplasms (Cancer) 09/2020 - 11/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2019 - 12/2015
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2014
1	Hypothyroidism 07/2023
1	Diabetes Insipidus 07/2023
1	Edema (Dropsy) 07/2023
1	Eosinophilia 07/2023
1	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2020
1	Dacryocystitis (Dacryoadenitis) 11/2020
1	Colonic Neoplasms (Colon Cancer) 09/2020
1	Glioma (Gliomas) 11/2019
1	Glioblastoma (Glioblastoma Multiforme) 11/2019
1	Ulcerative Colitis 06/2019
1	Brain Diseases (Brain Disorder) 01/2018
1	Urethritis 01/2018
1	Ileus 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2017
1	Alzheimer Disease (Alzheimer's Disease) 05/2017
1	Prostatic Neoplasms (Prostate Cancer) 12/2015
1	Blindness (Hysterical Blindness) 01/2014
1	Ganglion Cysts (Ganglion) 08/2013
1	Glaucoma 02/2013

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 05/2022 - 08/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 01/2018
2	ProgranulinsIBA 03/2016 - 01/2014
1	Immunoglobulin G (IgG)IBA 07/2023
1	Growth Hormone (Somatotropin)IBA 07/2023
1	GlucocorticoidsIBA 07/2023
1	ArginaseIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 09/2020
1	Essential Amino AcidsIBA 09/2020
1	Leucine (L-Leucine)FDA Link 09/2020
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 09/2020
1	Alkylating AgentsIBA 11/2019
1	Temozolomide (Temodar)FDA LinkGeneric 11/2019
1	Mustard Gas (Sulfur Mustard)IBA 11/2019
1	Arachidonic Acid (Vitamin F)IBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2019
1	Phospholipases A2 (Phospholipase A2)IBA 11/2019
1	Sunitinib (Sutent)FDA Link 11/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2019
1	fosphenytoin (Cerebyx)FDA LinkGeneric 01/2018
1	Spectinomycin (Spectinomycin Hydrochloride)FDA Link 01/2018
1	CannabinoidsIBA 01/2018
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2018
1	Delayed-Action PreparationsIBA 01/2018
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	RimonabantIBA 05/2017
1	EndocannabinoidsIBA 05/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2016
1	TubulinIBA 12/2015
1	Subfamily B ATP Binding Cassette TransporterIBA 12/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2015
1	Docetaxel (Taxotere)FDA Link 12/2015
1	TOR Serine-Threonine KinasesIBA 12/2015
1	cabazitaxel FDA Link 12/2015
1	taxaneIBA 12/2015
1	MTOR InhibitorsIBA 12/2015
1	Tyrosine Kinase InhibitorsIBA 12/2015
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Conditioned Culture MediaIBA 11/2013
1	N-Methylaspartate (NMDA)IBA 08/2013
1	Bimatoprost (Lumigan)FDA Link 02/2013
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 02/2013
1	Metallothionein 3IBA 11/2012

Therapy/Procedure

3	Therapeutics 07/2023 - 01/2014
1	Aftercare (After-Treatment) 07/2023
1	Oral Administration 11/2019
1	Castration 12/2015